Stimulated human monocytes/macrophages are a source of mediators such as tumor necrosis factor a
of the monocyte/macrophage lineage have receptors for IL-4; binding of IL-4 induces many products similar to those induced in B cells-e.g., major histocompatibility complex class I and class II antigens (16, 17) and CD23 (18) . Recently, IL-4 was identified as a factor stimulating human monocyte differentiation in vitro in that it caused changes in monocyte morphology, up-regulated many differentiation-linked antigens, and reduced the capacity of the cells to secrete an uncharacterized IL-1-like activity (19) . Other functions of monocytes/macrophages-e.g., antibody-dependent cell cytotoxicity-are unaffected by IL-4 (20) .
We report here that purified recombinant human IL-4 inhibited the ability of human monocytes to produce TNF-a, IL-1, and prostaglandin E2 (PGE2). For TNF-a and IL-13 [the major form of IL-1 produced by human monocytes (21) ], this inhibition occurred, at least in part, at the level of mRNA. The IL-4 effects were similar to those found with the corticosteroid dexamethasone (Dex).
Tumor necrosis factor a (TNF-a), interleukin 1 (IL-1), and arachidonic acid metabolites, such as prostaglandins, are produced by stimulated monocytes/macrophages and have been implicated in many of the inflammatory, immunological, hematological, and metabolic changes occurring during infection and tissue injury (for reviews, see refs. 1 and 2). For example, TNF-a and IL-1 (IL-la and IL-1f) are endogenous pyrogens (3) that induce proteases and alter arachidonic acid metabolism in a number of cell types (4), cause cartilage degradation in vitro (5) , and induce the synthesis of hepatic acute-phase proteins (2) . Prostaglandins, thromboxanes, and prostacyclins are likely to be involved in pain, edema, and other vascular changes (6) .
Glucocorticoids, which are potent and widely used antiinflammatory drugs, inhibit monocyte/macrophage TNF-a and IL-1p production at the transcriptional and posttranscriptional levels (7, 8) . The suppression by glucocorticoids of the production of prostanoids, most likely by blocking phospholipase A2 activity (9) , may also explain in part how these steroids are acting as antiinflammatory drugs (7, 10) . However, the side effects of corticosteroid therapy have limited their use for long-term treatment (10) , and alternative therapeutic agents are required.
Interleukin 4 (IL-4), a 20-kDa product from activated T lymphocytes, was originally described (and called B-cell stimulatory factor 1) by its ability to stimulate the entry of murine anti-IgG-activated B cells into the S phase of the cell cycle (11) . However, this lymphokine also has a variety of stimulatory and inhibitory actions on B and T cells (for reviews, see refs. 12 and 13; also see refs. 14 and 15). Cells MATERIALS AND METHODS Monocyte Isolation. As previously described (22, 23) , mononuclear cells were selected by centrifugation (170 x g for 30 min) of leukocyte-rich fractions (Melbourne Red Cross Blood Bank) on pyrogen-tested Lymphoprep (Nycomed, Oslo) and suspended in Hanks' balanced salt solution (Commonwealth Serum Laboratories, Melbourne, Australia) containing 0.21% sodium citrate, polymyxin B sulfate (Sigma) at 1 ,ug/ml, and neomycin sulfate at 70 ,.g/ml. Monocytes were isolated by countercurrent centrifugal elutriation (Beckman JE-6B Elutriation System) with a constant rotor speed (2000 rpm) but increasing pump rates from 8 to 22 ml/min. For each elutriation process, monocyte fractions were collected at a rate between 14.5 and 22.0 ml/min; monocyte enrichment> 90% was confirmed by cell morphology on Giemsa-stained cytocentrifuged smears and by nonspecific esterase staining.
Lymphocytes were the main contaminating cell type; polymorphonuclear cells always were 3% or less (22, 23) .
Monocyte Culture. Monocyte-rich fractions were pooled and resuspended in a-modified Eagle's medium (a-MEM;
Flow Laboratories) supplemented with 20 mM 3-(N-morpholino)propanesulfonic acid (Sigma), 13.3 mM NaHCO3, 2 mM glutamine, 50 AM 2-mercaptoethanol, 70 ,g of neomycin sulfate per ml, and 1% fetal calf serum (Flow) (complete a-MEM) with an osmolarity of 290 mmol/kg (22, 23) . Cells (0.8 x 106 to 1.0 x 106) were cultured in 1 ml of medium in 2-cm2 tissue culture plastic wells (Linbro). Where indicated, Abbreviations: IL-1 and -4, interleukins 1 and 4; TNF-a, tumor necrosis factor a; PGE2, prostaglandin E2; IFN-y, y interferon; LPS, lipopolysaccharide; Dex, dexamethasone; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; mAb, monoclonal antibody.
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the lymphokines (0.01 ml) were added at the following final concentrations: IL-4, 0.01-5.0 unit(s)/ml; IFN-y, 100 units/ ml (23) . Lipopolysaccharide (LPS) from Escherichia coli 0111:B4, purified by the Westphal method (Difco), was added to a final concentration of 100 ng/ml. Polymyxin B sulfate, which inhibits LPS binding to cell membranes, was added at 1 pug/ml to LPS-free cultures. Triplicate cultures for each test variable were incubated at 370C in 5% C02/95% air for 4 or 18 hr and were terminated by the removal, centrifugation (170 x g for 7 min), and storage of the supernatant at -20'C until assay. In many experiments, the adherent cells, together with those pelleted by centrifugation of the culture media, were lysed by Zaponin (Coulter), and the nuclei were quantitated in a Coulter Counter (22, 23) . In all experiments after 18 hr in culture, regardless of the lymphokines/reagents added, there was no change in the number of monocyte nuclei recovered; therefore, mediator activities released into the culture supernatants were expressed according to the number of cells at the beginning of the 18-hr culture.
Assays of TNF-a. Bioassay. TNF-a activity was measured as described (22, 23) with actinomycin D-treated L929 target cells. One unit of TNF-a activity was defined as the amount that caused 50% destruction (i.e., 50% absorbance change) of the L929 cells; the units of TNF-a activity in the monocyte culture supernatants were expressed as the reciprocal of the dilution necessary to achieve 50% cell cytotoxicity. For each assay, a dose-response curve using a recombinant TNF-a standard was constructed; 1 unit/ml 5 pM. The assay was sensitive to TNF-a levels of 0.1 pM. The blocking of cytotoxic activity in monocyte supernatants by an anti-TNF-a monoclonal antibody (mAb; 0.7 ug/ml) was confirmed in all assays (22, 23) .
RIA. Immunoreactive TNF-a was measured as described (23) . Standards or culture supernatants (0.1 ml) were mixed with 0.1 ml of diluted (1:400) rabbit antiserum to recombinant human TNF-a and were incubated for 24 hr. 1251I-labeled TNF-a (0.05 ml, 21.9 ,Ci/,ug, 4500 pg/ml; 1 uCi = 37 kBq) was added and incubated for 5-6 hr at room temperature. Bound and free TNF-a were separated by adding 0.05 ml of a 50% slurry of protein A-Sepharose beads (Pharmacia). TNF-a levels 2 100 pg/ml could be detected.
Assays of IL-1. Bioassay. IL-1 was assayed by the murine thymocyte comitogenesis assay (22, 23) . One unit of IL-1 activity was defined as the amount that stimulated 50% maximal thymocyte proliferation. IL-1 activity in the monocyte supernatants was measured at multiple dilutions (each dilution in duplicate) with the expressed activity being the reciprocal of the dilution giving half-maximal [3H]thymidine incorporation. In each assay, a standard curve was constructed by using a recombinant IL-1f3 standard; a standard of 1 unit/ml was approximately equal to 5 pM. Specific antibodies to IL-la and to IL-1,8 confirmed previous reports (21) that human monocytes secrete predominantly IL-1p.
None of the lymphokines or reagents used to stimulate monocytes in vitro acted as a comitogen for thymocytes under the culture conditions described.
ELISA. An adaption of the assay described by Kenney et al. (24) was used. Polyvinyl chloride microtiter wells (Dynatech) were coated overnight at 4°C with 0.05 ml of an anti-IL-1f3 mAb (IgG1; 30 jig/ml in 50mM NaHCO3, pH 9.0), and nonspecific binding was blocked with 2.5% bovine serum albumin. Samples or standards (0.05 ml) were added for 2 hr, followed by biotinylated anti-IL-1l3 mAb (0.05 ml, 1 ,ug/ml) for 2 hr and streptavidin-biotinylated horseradish peroxidase complex (diluted 1:1000, 0.05 ml; Amersham) for 1.5 hr. Between each procedure, the wells were washed with phosphate-buffered saline containing 0.1% Tween-20. The substrate mixture, 0.05% 2,2'-azinobis(3-ethylbenzthiazoline-6-sulfonic acid), diammonium salt (Sigma)/0.09% H202/0.1 M trisodium citrate, pH 4.6, was added for 30 min. IL-1 levels were quantitated by absorbance readings at 414 nm. An IL-1p dilution curve was prepared for each assay by using an IL-1p standard from the National Institute for Biological Standards and Control, Hampstead, London; the assay was sensitive to 0.4 ng of IL-l13 per ml.
Assay of PGE2. Levels of PGE2 in monocyte culture supernatants (-0.03 ng/ml) were determined by immunoassay using competitive adsorption to dextran-coated charcoal (PGE2 3H/RIA Kit, Seragen) (22, 23) . All determinations were performed in duplicate, and the mean was used to calculate PGE2 levels by interpolation from a standard curve.
Assay of Protein Synthesis. Monocytes were cultured as outlined above except that leucine-free a-MEM (Flow) was used. [4,5-3H ]Leucine (Amersham TRK 510; 5 gCi/well) was added at the start of the 16-hr incubation time (16-hr pulse) or for the last 5 hr of this culture period (5-hr pulse). Adherent cells and cells pelleted by centrifugation of the medium were lysed with 0.5 ml of 0.2 M NaOH. CC13COOH-insoluble protein was harvested onto glass fiber filters, and the radioactivity was measured (25) .
Detection of mRNA. Total cellular RNA from 4-hr monocyte cultures was prepared as described (26) and fractionated (5 pkg per lane) on a formaldehyde-containing 1% agarose gel (27) prior to transfer to GeneScreenPlus nylon membrane (DuPont). Transfer of RNA, hybridizations, and labeling of cDNAs were as outlined (28) , except the hybridizations were performed at 450C. The relative radioactivity for bands on autoradiograms was estimated by laser scanning densitometry (LKB Ultrascan); the relative intensity of bands for the monocyte mediators, TNF-a and IL-1, was compared with the intensity scan of the autoradiogram for the internal control, glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Maintenance of LPS-Free Conditions. All equipment was of a plastic disposable nature whenever possible (22, 23) . Glassware was soaked in 1% E-Toxiclean (Sigma) and, after washing, was heated to 240°C. All buffers and media were filtered through Zetapor membranes (AMF Cuno). LPS levels < 10 pg/ml in all reagents were confirmed in the Limulus lysate assay (Commonwealth Serum Laboratories).
Reagents. Recombinant human IL-4 (>400 units/,ug) (29) was obtained from A. Van Kimmenade, DNAX (Palo Alto, CA). Activity of 1 unit/ml was defined to give half-maximal growth of phytohemagglutinin-activated T cells. Reagents were obtained as gifts from the following people: recombinant human IFN-y at 1.5 x 107 units/mg (E. Hochuli, Hoffmann-La Roche, Basel); recombinant human TNF-a at 2.5 x 107 units/mg and a mAb to TNF-a with a neutralization titer of 6000 units of TNF-a per ,g of mAb (G. R. Adolf, Ernst-Boehringer Institut, Vienna); polyclonal rabbit anti-TNF-a for the RIA (M. Vadas and J. Gamble 
RESULTS
Effect of IL4 on Levels of Monocyte TNF-a Activity. There was no TNF-a activity detected in the supernatants of human monocytes cultured for 18 hr with IL-4 [0.01-5.0 unit(s)/ml]. In contrast, IL-4 at concentrations as low as 0.1 unit/ml suppressed the TNF-a activity induced by LPS ( Fig. 1 , P < 0.05 for 0.1 unit of IL-4 per ml). Decreasing concentrations of IL-4 were investigated for monocytes from two additional donors; for both, 0.1 unit of IL-4 per ml was sufficient to inhibit significantly LPS-induced TNF-a activity. Maximal inhibitory activity of IL-4 was consistently seen with =2.5 units/ml (300 pM); when results for monocytes from a number of donors were examined, IL-4 at 2.5 units/ml reduced the mean TNF-a activity induced by LPS from 27.2 (± 10.7) units per 106 cells to 1.5 (± 0.7) units per 106 cells (± SEM; n = 10, P < 0.01). IL-4 did not affect the L929 cytotoxicity assay. This inhibitory effect ofIL-4 on monocyte TNF-a activity was seen as early as 4 hr after simultaneous incubation of the cells with IL4 and LPS; for the two donors investigated at this time point, mean TNF-a activities decreased from 54 and 5.3 units per 106 cells to 14 and 0.9 unit(s) per 106 cells, respectively, in the presence of 2.5 units of IL4 per ml.
IFN-y, although not able to induce TNF-a activity, can synergize strongly with LPS to increase the TNF-a activity of human monocytes (22, 30) . Addition of IL-4 suppressed the TNF-a activity resulting from the synergistic action of LPS/IFN-y; for monocytes from five donors, 2.5 units of IL-4 per ml reduced TNF-a activities from 840 (± 314) units per 106 cells to 462 (± 273) units per 106 cells (± SEM; P < 0.05). For the three donors investigated, addition of 0.5 unit of IL4 per ml was sufficient for significant suppression ofthe TNF-a activity induced by LPS/IFN-y (P < 0.05).
Effect of IL-4 on Immunoreactive TNF-a Levels. To confirm that differences in the production of TNF-a protein were responsible for the decreases in TNF-a activity rather than inhibitors or an effect of IL-4 on the detection of TNF-a bioactivity, we determined whether IL-4 lowered the TNF-a levels as measured by RIA. An inhibitory effect of IL-4 was again observed (Fig. 2) for the same samples for which results are presented in Fig. 1 . In response to IL-4 at 2.5 units/ml, immunoreactive TNF-a levels induced by LPS decreased from 1.14 (± 0.55) ng per 106 cells to 0.09 (± 0.04) ng per 106 cells (± SEM; n = 7, P < 0.01). IL4 also significantly suppressed TNF-a protein levels induced by LPS/IFN-y Effect of IL4 on TNF-a mRNA Levels. IL-4 lowered the increased TNF-a mRNA levels resulting from the action of LPS and LPS/IFN-y (Fig. 3A) ; Fig. 3B shows that the intensities of the different bands were not significantly different when probed for GAPDH. The intensities of the radioactive bands after hybridization with the TNF-a probe were estimated by laser scanning densitometry and expressed as a function of the intensity of the corresponding GAPDH bands. IL-4 lowered the relative TNF-a mRNA levels in the LPS-treated and LPS/IFN--treated cultures by 65% and 60%o, respectively; it was also observed in Fig. 3A that the TNF-a mRNA levels in control cultures were lowered by IL-4. RNA blots from other donors showed similar reductions in TNF-a mRNA in response to IL-4.
Effect of IL-4 on IL-1 Levels. To determine the specificity of the inhibitory action of IL-4, we examined the effect of IL-4 on monocyte-derived IL-1 activity. IL Effect of Glucocorticoids on TNF-a and IL-1 Levels. Dex (0.1 gM) and IL-4 (2.5 units/ml; 300 pM) were both potent in inhibiting the stimulatory effect of LPS ( (Fig. 5 ) in a manner very like that seen for the production of TNF-a (Figs. 1 and 2 ) and of IL-1 (Fig. 4) . In response to IL-4 (2.5 units/ml), PGE2 levels induced by LPS decreased from 14 Up until now the actions of IL-4 on human monocytes have generally been considered to be stimulatory (16) (17) (18) . The present data show that IL-4 can also inhibit some parameters of human monocyte activation. Thus, another function is added to the list of the pleiotropic effects of IL-4. The results of this study suggest that IL-4 may indeed be a powerful, previously unrecognized antiinflammatory agent.
